Chordoma at the Base of the Skull

Chordoma at the Base of the Skull Chordoma at the base of the skull is a rare and aggressive cancer. It comes from leftover parts of the notochord. This structure is there during the early stages of growth and usually goes away. But sometimes, it stays and turns into a chordoma.

This type of cancer grows slowly, but finding it early is key to treating it well. Knowing about it helps doctors help patients better.

What is Chordoma?

Chordoma is a rare cancer that comes from leftover parts of the notochord. This is a structure from when we were growing inside our mom. It usually happens in the skull base and spine bones. Because of where they grow, chordomas are also known as skull base tumors. They grow slowly but can spread a lot, hurting nearby tissues.


Get Free Consultation

Please enable JavaScript in your browser to complete this form.
Step 1 of 4
Select Your Gender

ACIBADEM Health Point: The Future of Healthcare

We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.

Definition and Background

Chordoma is a kind of sarcoma, which is cancer that starts in bones and soft tissues. It mostly happens in adults, especially men. We don’t really know why chordomas happen, but genes might play a big part. The World Health Organization says chordoma is its own type of bone cancer.

Chordomas are hard to treat with surgery and radiation. So, we need to understand them better to find new ways to help.

Types of Chordoma

Chordomas can be different types based on where they grow and how they look under a microscope. These include:


ACIBADEM Health Point: Your Health is Our Priority!

ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.
  • Clival Chordomas: These are in the skull base, near the brain and nerves.
  • Cervical Chordomas: These are in the neck spine.
  • Thoracic Chordomas: These are in the middle spine.
  • Lumbar Chordomas: These are in the lower back.
  • Sacral Chordomas: These are in the sacrum, at the spine’s base. They are the most common type.

Each type of chordoma has its own symptoms and challenges. For example, clival chordomas can hurt the nerves in the head. Sacral chordomas might cause back pain and other nerve problems.

Dealing with chordomas is hard and needs a team of doctors. New research has led to better treatments, helping patients more.

Symptoms of Chordoma at the Base of the Skull

Knowing the symptoms of chordoma at the base of the skull helps with early diagnosis. This is key for better treatment results.

Early Signs

The first signs of chordomas are often small and easy to miss. They might include:

  • Recurrent headaches
  • Neck pain
  • Facial pain or numbness
  • Slight hearing loss

These early signs are not clear-cut, making it hard to spot chordoma early. It’s important to take these symptoms seriously if they don’t go away or get worse.

Advanced Symptoms

As chordomas grow, the symptoms get worse and more serious. Look out for these signs:

  • Cranial nerve dysfunction
  • Double vision
  • Difficulty swallowing
  • Facial muscle weakness
  • Loss of coordination

As the tumor gets bigger, it can harm nerves and other parts nearby. Spotting these signs early is key for good treatment and care.

Causes and Risk Factors

Chordoma is a rare tumor that can be hard to understand. It often happens without a clear reason. But, scientists have found some things that might make getting chordoma more likely. These tumors usually grow in the skull base.

Genetic Factors

Genes play a big part in getting skull base cancer, like chordoma. Some genes have changes that make getting chordoma more likely. For example, a gene called T gene is linked to chordoma.

Some families have more cases of chordoma, showing it might run in families. Studies by Genetics Home Reference confirm this.

Environmental Influences

Researchers are still looking into how the environment affects chordoma. So far, they haven’t found clear links to specific environmental factors. Cancer Epidemiology, Biomarkers & Prevention says there’s no strong proof yet.

This means we focus more on genes and catching it early for better treatment.

Diagnosing Chordoma

Finding chordoma at the skull base needs advanced tests. First, doctors use non-invasive tests to see the affected area clearly.

Medical Imaging Techniques

Tests like MRI and CT scans are key in spotting chordoma. MRI shows soft tissues well, perfect for chordomas near important parts. CT scans help see bone details and the tumor’s shape. These tests help plan treatment and see how deep the tumor goes.

Biopsy Procedures

Imaging helps, but biopsies confirm the diagnosis. They take tissue samples for closer look. There’s needle biopsy and open surgery to get tissue.

Both are important to know the cell type and confirm chordoma. This guides the right treatment.

Chordoma Base of Skull Treatment Options

Treating chordoma at the base of the skull is complex. It’s because of its tough spot and the chance of it coming back. The main way to treat it is surgery. Surgeons try to take out as much of the tumor as they can without harming important parts.

Skull base surgery needs a team of experts. This includes neurosurgeons and otolaryngologists. They work carefully around nerves and blood vessels. MRI and CT scans help plan these tricky surgeries.

  • Surgical Resection: Sometimes, taking out the whole tumor isn’t possible. In those cases, taking out part of it can help. This reduces its size and lessens harm to nearby tissues.
  • Radiation Therapy: After surgery, radiation therapy is often used. It kills any cancer cells left behind. Proton beam therapy is used to target the tumor without harming healthy tissue nearby.
  • Chemotherapy: Chemotherapy is not usually the first choice for chordoma. But, it might be used in some cases. This is when the tumor is very aggressive or keeps coming back.

Experts from the International Journal of Medical Sciences and the Chordoma Foundation stress the need for treatments made just for each patient. New research and surgery methods are making things better for people with this tough condition.

Advances in Skull Base Surgery

Recent years have seen big steps forward in skull base surgery. This includes managing chordomas at the skull’s base. The goal is to cut down on patient trauma and improve recovery chances. New methods include less invasive surgery and look promising for patients.

Minimally Invasive Techniques

One big step is the use of minimally invasive surgery. Endoscopic surgery has changed how we treat skull base tumors. It uses small, flexible tools and cameras to reach the tumor through small openings.

Studies in the Journal of Neurosurgery: Skull Base show these methods cut down recovery times and fewer complications. This is compared to old-style open surgery.

  • Reduced hospital stay
  • Lower infection risk
  • Minimal scarring
  • Faster return to daily activities

Recovery and Prognosis

Using these new techniques has also made recovery better for skull base surgery patients. The Neurosurgical Review says patients get better faster and have better results. Chordoma patients treated this way have lower chances of coming back.

This means they often need less treatment after surgery. This helps their recovery even more. Researchers are working to make these methods even better, as seen in World Neurosurgery.

Prognosis and Survival Rates

The chordoma prognosis depends on many things like tumor size, where it is, and surgery success. Studies from the Journal of the National Cancer Institute show how these factors affect survival rates.

Knowing survival rates helps us understand what the future holds for chordoma patients. How much of the tumor is removed and how aggressive it is matters a lot. The American Journal of Roentgenology found that removing more of the tumor usually means better survival chances.

Here is an overview of survival rates based on different prognostic factors:

Factor Influence on Survival Rates
Tumor Size Larger tumors tend to have lower survival rates
Location Base of the skull tumors might have more complications
Extent of Resection Complete resection is associated with better prognosis
Age of Patient Younger patients generally have higher survival rates

Studies in Cancer stress the need for custom treatment plans and regular check-ups. This way, doctors can help improve the chordoma prognosis. They work to give patients the best treatments possible.

Ongoing Chordoma Research

Research on chordoma has made big steps forward. Now, we’re working hard to find new ways to treat it. We want to make treatments better and help patients more.

Clinical Trials

Many clinical trials are happening to test new treatments for chordoma. These clinical trials look at things like targeted therapies and new ways to fight cancer. We want to find the best ways to treat chordoma at the skull base and other places.

You can learn more about these trials on ClinicalTrials.gov and the Chordoma Foundation.

Innovative Therapies

Researchers are also looking at new therapies for chordoma. These therapies target specific parts of the tumor and use the immune system to fight cancer. Articles in Cancer Discovery talk about these new treatments. They show how they could help chordoma patients live longer and better.Chordoma at the Base of the Skull

Research Focus Details Impact
Targeted Therapies Developing drugs that specifically target cancer cells Increased precision in treatment, reducing damage to healthy cells
Immunotherapy Using the immune system to fight cancer Enhanced ability to control tumor growth and reduce recurrence
Clinical Trial Outcomes Results from ongoing studies Better understanding of treatment efficacy and potential new standards of care

FAQ

What is chordoma at the base of the skull?

Chordoma at the base of the skull is a rare cancer. It comes from leftover parts of the notochord, a structure in early development. It grows slowly but needs early finding for better treatment.

What are common symptoms of chordoma at the base of the skull?

Early signs of chordoma include headaches or neck pain. Later, it can cause problems like double vision, numbness in the face, or trouble swallowing.

How is chordoma diagnosed?

Doctors use MRI and CT scans to see the tumor. They also do biopsies to check the tumor's cells.


ACIBADEM Healthcare Group Hospitals and Clinics

With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now !

*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of ACIBADEM Health Group.